Physician profile
Gregory B Davis
NPI 1356401558
$7,722.08
in general payments reported to CMS, 2019-2025
13 companies · $146 in 2025
The $146 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $1,083 · 2021: $172 · 2022: $5,875 · 2023: $92.77 · 2024: $211 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.72 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $5,851.84 | 2020-2025 | Bridion |
| Acelrx Pharmaceuticals, INC. | $1,016.70 | 2020-2021 | |
| Avanos Medical | $370.88 | 2019-2025 | On-Q Pump and Accessories |
| Cumberland Pharmaceuticals, INC. | $144.62 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $123.76 | 2024 | Iovera |
| Masimo Corporation | $92.46 | 2022-2024 | Sedline, Set and Rainbow Set |
| Qol Medical, LLC | $26.85 | 2022 | |
| Grifols USA, LLC | $21.35 | 2025 | Thrombate III |
| Trevena, INC. | $16.29 | 2022 | |
| Covidien LP | $15.52 | 2020 | |
| Abbvie INC. | $14.58 | 2024 | |
| Acacia Pharma INC | $14.32 | 2022 | |
| Medtronic, INC. | $12.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.